NCT00161941已完成不适用
Open-label Multicenter Phase 3B Follow-up Study to Investigate the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens One Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in the NeisVac-C Non-interference Study 216
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 321
- 试验地点
- 11
研究概览
简要总结
The primary aim of the study is to show that the antibody response to hepatitis B, acellular pertussis toxin and inactivated poliovirus antigens after the 4th vaccination with Hexavac® is not influenced by the concomitant administration of NeisVac-C.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5 Months 至 22 Months（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Study subjects who completed study 216 will be eligible for participation in this study if:
- •they received all 3 vaccinations with Hexavac during study 216 and the 4th Hexavac vaccination outside the study
- •the subject's parent(s)/legal guardian(s) understands the study and has provided written informed consent for his/her child's study participation;
- •a blood draw was performed after the 3rd vaccination during study 216.
排除标准
- •Study subjects will be excluded from participation in this study if:
- •they have received any vaccination containing hepatitis B, poliovirus or acellular pertussis toxin antigens other than Hexavac
- •they have received a blood transfusion or immunoglobulins during the period from 28 days prior to the 4th Hexavac vaccination until study entry
- •they have received another vaccine during the period from 28 days prior to the 4th Hexavac vaccination until study entry
- •they are concurrently participating in or have participated in a clinical trial with an investigational medicinal product since the completion of study 216
- •they suffer from a disease (e.g. autoimmune disease) or were undergoing a form of treatment that may be expected to influence immunological functions since the completion of study 216
- •they have received systemic corticosteroids during the period from 28 days prior to the 4th Hexavac vaccination until study entry.
研究者
研究点 (11)
Loading locations...
相似试验
终止
2 期
A Study of JNJ-73763989, Pegylated Interferon Alpha-2a and Nucleos(t)Ide Analogs in Participants With Chronic Hepatitis B Virus InfectionHepatitis B, ChronicNCT05005507Janssen Research & Development, LLC1
已完成
4 期
Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old ChildrenHepatitis BNCT04294433Laval University431
已完成
2 期
A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus InfectionHepatitis BNCT04585789Janssen Research & Development, LLC24
已完成
4 期
A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy AdultsHepatitis BNCT02203357Peking University353
招募中
2 期
Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]Hepatitis B, ChronicNCT06216470University Health Network, Toronto15